FindTrial
Sign In

to study the the effect and advantages of Intra-articular Steroid Injections over Pericapsular Nerve Group (PENG) Block injection for the treatment of shoulder pain.

A Randomized Controlled Trial Comparing the Efficacy of Intra-articular Steroid Injection and Pericapsular Nerve Group (PENG) Block for Pain Control and Functional Outcomes in Patients Undergoing Manipulation Under Anesthesia (MUA) for Frozen Shoulder. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090431
Enrollment
126
Registered
2025-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system Health Condition 3: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Intra-articular Steroid Injection: (Intra-articular Steroid Injection Under sterile conditions, a corticosteroid (inj Triancinolone 40mg) with 2%2ml and 0.5% Bupivacine 2ml will be inje

Sponsors

Deaparment of anestehsiopgy
Lead Sponsor
Depart of Orthopediac and Rehabilitation
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Candidates for MUA based on clinical evaluation and failure of conservative management Willingness to participate and provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to regional anesthesia or steroid use (e.g., infections, allergy, coagulopathy). 2. Previous shoulder surgery or trauma. 3. Neurological or other musculoskeletal disorders affecting shoulder function. 4. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Pain reduction (NPRS) within 24 hours post-MUA. Timepoint: 24 hours—

Secondary

MeasureTime frame
Change in shoulder ROM from baseline to post-MUA & follow-up visits. Functional improvement as measured by SPADI scores.Duration of analgesia. Incidence of complications or adverse effects. Timepoint: 1 week—

Countries

India

Contacts

Public ContactDr Sangeeta Dhanger

Indira Gandhi Medical College & Research Institute

drsangeeta06@gmail.com848165915

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026